Prostatis Group’s Strive Enhanced Income Short Maturity ETF BUXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Sell
83,695
-3,514
-4% -$71.1K 0.39% 53
2026
Q1
$1.77M Buy
87,209
+142
+0.2% +$2.88K 0.45% 52
2025
Q4
$1.76M Buy
87,067
+19,174
+28% +$389K 0.42% 52
2025
Q3
$1.38M Sell
67,893
-7,759
-10% -$158K 0.35% 63
2025
Q2
$1.54M Buy
75,652
+10,201
+16% +$207K 0.44% 54
2025
Q1
$1.33M Sell
65,451
-3,401
-5% -$69.2K 0.42% 53
2024
Q4
$1.4M Buy
+68,852
New +$1.4M 0.41% 58
2024
Q3
Sell
-32,294
Closed -$654K 131
2024
Q2
$654K Buy
+32,294
New +$654K 0.23% 85

Other funds holding BUXX

Prostatis Group's BUXX Position: Q2 2026 in Review

Prostatis Group reduced its Strive Enhanced Income Short Maturity ETF (BUXX) stake by 4% in Q2 2026, selling an estimated $71.1K and leaving 83,695 shares worth $1.69M. The position accounts for 0.39% of the portfolio, ranked #53.

Prostatis Group first reported a position in BUXX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.77M in Q1 2026. 67 funds tracked by Wall St. Rank hold BUXX as of Q2 2026.

  • Prostatis Group held 83,695 shares of Strive Enhanced Income Short Maturity ETF worth $1.69M as of Q2 2026.
  • Prostatis Group sold 3,514 Strive Enhanced Income Short Maturity ETF shares in Q2 2026, an estimated $71.1K.
  • Strive Enhanced Income Short Maturity ETF made up 0.39% of Prostatis Group's portfolio in Q2 2026, its #53 holding.
  • Prostatis Group first reported a position in Strive Enhanced Income Short Maturity ETF in Q2 2024 and has held it in 8 quarters since.
  • Prostatis Group's Strive Enhanced Income Short Maturity ETF position peaked at $1.77M in Q1 2026.
  • 67 funds tracked by Wall St. Rank held Strive Enhanced Income Short Maturity ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.